Frankly Speaking About Lung Cancer - PowerPoint PPT Presentation

1 / 49
About This Presentation
Title:

Frankly Speaking About Lung Cancer

Description:

... About Lung Cancer ... Frankly Speaking About Lung Cancer. The Wellness Community. national non ... Lung cancer is the #1 cause of cancer-related deaths by ... – PowerPoint PPT presentation

Number of Views:279
Avg rating:3.0/5.0
Slides: 50
Provided by: GSW
Category:

less

Transcript and Presenter's Notes

Title: Frankly Speaking About Lung Cancer


1
(No Transcript)
2
Frankly Speaking About Lung Cancer
  • The Wellness Community provides a free program of
    emotional support, education and hope for people
    with cancer and their loved ones.

3
Frankly Speaking About Lung Cancer
  • The Wellness Community
  • Patient Active Concept
  • Cancer patients who participate in their fight
    for recovery along with their healthcare team
    will improve the quality of their lives and may
    enhance the possibility of recovery.

4
Frankly Speaking About Lung Cancer
  • The Wellness Community
  • national non-profit organization
  • 21 locations nationwide 2 international
  • over 12,000 support group sessions
  • 138,000 visits each year
  • Research, publications
  • The Virtual Wellness Community

5
The Wellness Community Programs
  • Nutritional education
  • Stress reduction programs (Tai Chi, Yoga, etc.)
  • Exercise programs
  • Childrens programs
  • Resource library
  • Social activities
  • Weekly patient support groups
  • Weekly family support groups
  • Diagnosis specific networking groups
  • Bereavement groups
  • Educational programs

All programs are free of charge!
6
Frankly Speaking About Lung Cancer
  • What You Need to
  • Know About Lung Cancer
  • Its Treatment

7
Frankly Speaking About Lung Cancer
  • Powerful facts
  • 177,000 cases annually
  • Lung cancer is the 1 cause of cancer-related
    deaths by far in the U.S.
  • more than breast, prostate, and colon cancer
    combined.

8
Frankly Speaking About Lung Cancer
  • Risk Factors
  • Smoking (90 of all cases)
  • Second-hand smoke (25 of non-smoker cases)
  • Occupational/environmental

9
Frankly Speaking About Lung Cancer
  • Non-Small Cell Lung Cancer (NSCLC)
  • Comprises 85 of all lung cancers
  • Types of NSCLC
  • Adenocarcinoma (most common)
  • Squamous cell
  • Bronchoalveolar Carcinoma
  • Large Cell Carcinoma
  • Adenosquamous

10
Frankly Speaking About Lung Cancer
  • Small Cell Lung Cancer (SCLC)
  • Comprises 15-20 of all lung cancers
  • Spreads more aggressively than NSCLC
  • Is more responsive to chemotherapy
  • Frequently found in smokers or former smokers

11
Frankly Speaking About Lung Cancer
  • Stages of Non-Small Cell Lung Cancer
  • Stage I confined to lung tissue alone
  • Stage II lung tissue and lymph nodes in lung
  • Stage III lung tissue and lymph nodes outside
    of the lung
  • Stage IV distant spread (liver, adrenal
    glands, bone, brain, other sites)

12
Frankly Speaking About Lung Cancer
  • LUNG CANCER STAGING (TNM)
  • T Primary tumor size (T1-T4)
  • N Lymph node involvement (N1-N3)
  • M Distant metastasis (M0-M1)

13
Frankly Speaking About Lung Cancer
  • Treatment of Stage I NSCLC
  • Evaluate for surgery
  • Surgery alone is the standard of care
  • Pathologic stage I 67 cure
  • Clinical trials are evaluating the value of
    adjuvant (after surgery) therapy

14
Frankly Speaking About Lung Cancer
  • Treatment of Stage II NSCLC
  • Evaluate for type of surgery
  • Surgery alone is the standard of care
  • Pathologic stage II 40-50 cure
  • Clinical trials are evaluating the value of
    adjuvant (after surgery) therapy

15
Frankly Speaking About Lung Cancer
  • Theoretical Advantages of Combining Different
    Types of Cancer Therapies
  • Chemotherapy
  • ?Controls micro-metastases that may be
    responsible for systemic recurrence after
    successful surgery
  • ?Acts synergistically with XRT to downstage
    NSCLC and make tumor-free margin surgery more
    likely
  • Radiation Therapy
  • ? Sterilizes surgical margins making local
    recurrence less likely

16
Frankly Speaking About Lung Cancer
  • Summary Treatment Stage I II NSCLC
  • Surgery is the standard of care
  • Neoadjuvant (given before surgery) therapy is
    promising
  • Adjuvant (given after surgery) chemotherapy or
    radiation therapy show no improvement

17
Frankly Speaking About Lung Cancer
  • Stage III Non-Small Cell Lung Cancer
  • 2 types Stage IIIA and Stage IIIB
  • Radiation alone was the standard care until
    1990s
  • Chemotherapy radiation is the new standard
    based on results of clinical trials
  • Newer radiation techniques minimize side effects
    of treatment

18
Frankly Speaking About Lung Cancer
  • Treatment of Stage III NSCLC
  • Chemo radiation standard of care
  • Role of surgery is undefined
  • Unanswered questions
  • -Which chemo is best? How does one decide?
  • -When how should chemotherapy be given?
  • -When how should radiation be given?

19
Frankly Speaking About Lung Cancer
  • Stage III A Non-Small Cell Lung Cancer
  • Bulky vs. minimal disease
  • Chemotherapy radiation
  • Commonly used chemotherapy drugs
  • Platinum-based
  • Non-platinum based
  • Role of surgery undefined

20
Frankly Speaking About Lung Cancer
  • Stage III B Non-Small Cell Lung Cancer
  • Pleural effusion affects treatment plan
  • Chemotherapy radiation or radiation alone
  • Commonly used chemotherapy drugs
  • Platinum-based
  • Non-platinum based

21
Frankly Speaking About Lung Cancer
  • Treatment of Stage IIIB-IV NSCLC
  • Reduce Chemotherapy Toxicity
  • Recent study Combination of 2 drugs provide same
    benefit as 3, but with fewer side effects
  • Less nausea/vomiting
  • Less hair loss
  • Less nerve damage
  • Lower risk of infection
  • Gemcitabine vinorelbine slightly less toxicity
    but equivalent response
  • (Cancer, Vol. 95, No. 6, 2002)

22
Frankly Speaking About Lung Cancer
  • Stage IV NSCLC
  • NCI Recommended First-Line Chemotherapy
  • gemcitabine cisplatin
  • paclitaxel carboplatin or cisplatin
  • vinorelbine cisplatin
  • docetaxel cisplatin
  • Other drug combinations

23
Frankly Speaking About Lung Cancer
  • Treatment of Recurrent NSCLC
  • Challenges of decision-making
  • General health status of the patient
  • Several treatment options with equivalent results
    but widely varying side effects
  • Balancing quality of life with side effects
  • Patients goals and wishes

24
Frankly Speaking About Lung Cancer
  • Treatment of Recurrent NSCLC
  • NCI Recommended treatment options
  • Chemotherapy
  • vinorelbine cisplatin
  • paclitaxel cisplatin or carboplatin
  • gemcitabine cisplatin
  • docetaxel cisplatin
  • Other drug combinations
  • Palliative radiation therapy to relieve symptoms

25
Frankly Speaking About Lung Cancer
  • Treatment of Small Cell Lung Cancer
  • Limited stage chemo xrt standard of care
  • etoposide cisplatin radiation
  • cisplatin irinotecan
  • Extensive stage first-line chemotherapy
  • etoposide (VP-16) cisplatin (or carboplatin)
    radiation
  • cisplatin irinotecan
  • CAV, CAE in clinical trials

26
Frankly Speaking About Lung Cancer
  • Treatment of Recurrent Small Cell Lung Cancer
  • Possible Chemotherapy Agents
  • topotecan (Hycamtin) only FDA-approved drug for
    recurrent disease
  • oral etoposide (VP-16)
  • paclitaxel (Taxol)
  • irinotecan/CPT-11 (Camptosar)
  • CAV
  • others in clinical trials
  • Palliative radiation to relieve symptoms

27
Frankly Speaking About Lung Cancer
  • Newer Strategies Targeted Therapy
  • Chemotherapy targets general features of cells,
    including both cancer cells and normal cells
  • Normal cells usually recover, while cancer cells
    may not
  • However, chemotherapy is associated with side
    effects

28
Frankly Speaking About Lung Cancer
Examples of Lung Cancer Targeted Therapy in
Development
  • Epidermal Growth Factor Receptors
  • Angiogenesis
  • Antisense
  • Protein Kinase C
  • C-kit
  • PDGF-r
  • Cox-2
  • Ras inhibitors
  • Raf inhibitors
  • Map kinase
  • Others

29
Frankly Speaking About Lung Cancer
  • Epidermal Growth Factor Receptors
  • Iressa (AstraZeneca)
  • Tarceva (Genentech)
  • Erbitux (Imclone, BMS)
  • Many others in development

30
Frankly Speaking About Lung Cancer
  • Angiogenesis Inhibitors
  • Angioblood vessel, Genesisformation or
    beginning
  • Many agents being tested to inhibit this process
  • Anti-VEGF
  • Thalidomide
  • Angiostatin/Endostatin
  • Anti-VEGF tyrosine kinase inhibitors
  • Others

31
Frankly Speaking About Lung Cancer
  • Antisense Drugs
  • Affinitac (Lilly)
  • Antisense drug to protein kinase C
  • Phase II studies completed combining with
    chemotherapy
  • Evaluating effectiveness in recurrent lung cancer
  • Phase III trials underway comparing chemotherapy
    drug

32
Frankly Speaking About Lung Cancer
  • What You Need to
  • Know About Lung Cancer
  • Its Treatment
  • Questions and Discussion

33
Frankly Speaking About Lung Cancer
  • PATIENT ACTIVE BREAK

34
Frankly Speaking About Lung Cancer
  • Issues to Discuss With Your Doctor When Making
    Decisions About Lung Cancer Treatment
  • A Patient Active Approach

35
Frankly Speaking About Lung Cancer
  • Making decisions about cancer treatment is a
    complex and sometimes overwhelming experience.
  • You have choices. But you need to be informed
    you need to evaluate many aspects of your care.

36
Frankly Speaking About Lung Cancer
  • What is the goal of my cancer therapy?
  • Is it prolongation of life?
  • Is to control symptoms?
  • Is it palliation?

37
Frankly Speaking About Lung Cancer
  • What is a clinical trial and would one be a
    reasonable treatment option for me?
  • What are the risks and benefits?

38
Frankly Speaking About Lung Cancer
  • Clinical Trial Definitions
  • Phase I-new drug/treatment well-tested in the lab
    now testing toxicity in people
  • Phase II-new drug/treatment has given good
    preliminary results-test feasibility
  • Phase III-compares new drug/treatment vs standard
    of care

39
Frankly Speaking About Lung Cancer
  • What are the risks of treatment?
  • What are the risks of no treatment?
  • Should I seek a second opinion?

40
Frankly Speaking About Lung Cancer
  • Are there some treatments that have equal
    benefit, but fewer or different
  • side effects?
  • Can we discuss which side effects I would be most
    concerned about having or preventing?

41
Frankly Speaking About Lung Cancer
  • How do we balance my quality of life with my need
    for effective treatment?
  • How will we know that the treatment is working?
  • What can I expect to happen to me as the cancer
    progresses?

42
Frankly Speaking About Lung Cancer
  • Can I continue to work or maintain my other daily
    activities during treatment?
  • If I have pain, what should I do?
  • Nausea vomiting?
  • Fatigue?
  • Risk of infection?

43
Frankly Speaking About Lung Cancer
  • Why do some people who smoke get lung cancer
    while others dont?
  • Why did I get lung cancer if I never smoked?

44
Frankly Speaking About Lung Cancer
  • What kind of supportive resources are available
    to me and my family?
  • What can I expect from an emotional perspective?

45
Frankly Speaking About Lung Cancer
  • Questions to Ask Yourself
  • What can I do to be a stronger partner with my
    physician health care team?
  • What is my goal of therapy and have I expressed
    that to my physician?

46
Frankly Speaking About Lung Cancer
  • Am I ready and willing to participate fully and
    actively in my treatment plan?
  • Do I know what the potential side effects of
    therapy are and how best to prevent or manage
    them?
  • Have I communicated with my physician what
    quality of life means to me?

47
Frankly Speaking About Lung Cancer
  • How will I (and my family) address the emotional
    issues of living with lung cancer?
  • Is a support group right for me (and/or my
    family)?

48
Frankly Speaking About Lung Cancer
  • Making decisions about lung cancer and its
    treatment is never easy.
  • By being informed partnering with your
    physician health care team, you can improve the
    quality of your life and may enhance the
    possibility of your recovery.

49
Frankly Speaking About Lung Cancer
  • Making Decisions About Lung Cancer Treatment
  • Questions and Discussion
Write a Comment
User Comments (0)
About PowerShow.com